ReviewEnvironment & health (Washington, D.C.)2025
Opportunities and Challenges of Multiomics for Discovery and Monitoring of Human Pathogens.
Review in Environment & health (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Revisiting Animal Reservoirs of Hantavirus and Other Zoonotic Viruses Associated with Cruise Travel: Impact and Prevention.Animals : an open access journal from MDPI · 2026Review
- Biomolecular profiling for noninvasive health monitoring.Nature biotechnology · 2026Review
- Clinical Human-Derived Pathogen Signatures Captured by SERS and Deep Learning for Environmental Exposure Risk Assessment.Environment & health (Washington, D.C.) · 2026Article
- Synergism between Distribution, Mechanistic and Omics Analyses in Studies on Assessing Environmental Exposure and Human Health Impact.Environment & health (Washington, D.C.) · 2026Article
- Metagenomic next-generation sequencing reveals airway microbial dysbiosis and functional alterations inFrontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Detection and monitoring of pathogens is a central aspect of maintaining public health. Rare and neglected zoonotic viruses have the potential to evolve and expand exponentially, leading to unforeseen outbreaks, epidemics, and pandemics. The emerging multiomics and meta-omics techniques and workflows, such as proteogenomics and meta-genomics, offer the potential for the detection of harmful pathogens, as well as opportunities for the discovery of previously unknown bacterial, parasitic, or viral pathogens. Multiomics and meta-omics workflows provide molecular information for tracking pathogens and understanding the effectiveness of spread mitigation strategies. In addition to environmental monitoring, multiomics and meta-omics approaches have the potential for clinical applications and in-depth characterization of novel pathogens. In this review, we discuss recent applications of multiomics and meta-omics techniques, their advantages over traditional methods, and their potential implementations in biomedical research, environmental studies, and healthcare. We critically assess the benefits and challenges of multiomics and meta-omics studies and discuss their future perspectives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.